DOCSLIB.ORG

If You Plan to Claim MOC Points for This Activity, You Will Be Asked To

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

6/15/2020 Joint ACG/ANMS Webinar Restarting Your Motility Practice Participating in the Webinar All attendees will be muted and will remain in Listen Only Mode. Type your questions here so that the moderator can see them. Not all questions will be answered but we will get to as many as possible. 1 Joint ACG/ANMS Webinar Restarting Your Motility Practice How to Receive CME and MOC Points LIVE VIRTUAL GRAND ROUNDS WEBINAR ACG will send a link to a CME & MOC evaluation to all attendees on the live webinar. ABIM Board Certified physicians need to complete their MOC activities by December 31, 2020 in order for the MOC points to count toward any MOC requirements that are due by the end of the year. No MOC credit may be awarded after March 1, 2021 for this activity. ACG will submit MOC points on the first of each month. Please allow 3-5 business days for your MOC credit to appear on your ABIM account. 2 Joint ACG/ANMS Webinar Restarting Your Motility Practice MOC QUESTION If you plan to claim MOC Points for this activity, you will be asked to: Please list specific changes you will make in your practice as a result of the information you received from this activity. Include specific strategies or changes that you plan to implement. THESE ANSWERS WILL BE REVIEWED. 3 American College of Gastroenterology 1 6/15/2020 Joint ACG/ANMS Webinar Restarting Your Motility Practice ACG Virtual Grand Rounds Join us for upcoming Virtual Grand Rounds! Week 13: Health Maintenance for the Patient with IBD Francis A. Farraye, MD, MSc, FACG June 18, 2020 at Noon EDT Week 14: EOE and EGID: Pearls and Pitfalls Kathy A. Peterson, MD, Msci June 25, 2020 at Noon EDT Visit gi.org/ACGVGR to Register 4 Joint ACG/ANMS Webinar Restarting Your Motility Practice Disclosures: Dr. Pochapin Dr. Baker Dr. Gyawali Dr. Moshiree Dr. Chey Dr. Rao Dr. Khan Dr. Pandolfino According to ACCME guidance, because there are no current preventive or specific treatments for coronavirus infection, there are no relevant conflicts of interest for any speakers or moderators. 5 Joint ACG/ANMS Webinar Restarting Your Motility Practice 6 American College of Gastroenterology 2 6/15/2020 Joint ACG/ANMS Webinar Restarting Your Motility Practice Jason R. Baker, PhD Atrium Health University of North Carolina Charlotte 7 Joint ACG/ANMS Webinar Restarting Your Motility Practice • Personal Protective Equipment (PPE) and Motility/GI Physiology Laboratory related to COVID‐19 Pandemic • Motility/GI Physiology Laboratory workflow to protect Allied Health Professionals and Patients from spreading COVID‐19 • Suggested additional Motility/GI Physiology Laboratory suite air‐ filtration techniques related to COVID‐19 8 Joint ACG/ANMS Webinar Restarting Your Motility Practice • Primary reason to for Allied Health Professionals/Motility Providers to utilize appropriate PPE for GI Physiology/Motility Testing • GI Physiology/Motility Testing is a Partnership Relationship • Allied Health Professionals and Patient 9 American College of Gastroenterology 3 6/15/2020 Joint ACG/ANMS Webinar Restarting Your Motility Practice Motility Laboratory Procedure PPE Recommendations Esophageal Physiologic Procedures N95 mask, double gloves, face shield (and/or alternate protective eye wear), and gown Antroduodenal Manometry N95 mask, double gloves, face shield, (and/or alternate protective eye wear), and gown Colon Manometry N95 mask, double gloves, face shield (and/or alternate protective eye wear), and gown Wireless Motility Capsule N95 mask, or surgical mask with a face shield, gloves, face shield (and/or alternate protective eye wear), and gown Gastric Emptying Breath Test N95 mask, gloves, face shield (and/or alternate protective eye wear), and gown Anorectal Function Testing N95 mask or surgical mask with face shield (and/or alternate protective eye wear), double gloves, and gown Hydrogen Breath Testing N95 mask, gloves, face shield (and/or alternate protective eye wear), and gown 10 Joint ACG/ANMS Webinar Restarting Your Motility Practice Motility/GI Physiology Laboratory Test Scheduled 48 Hours Prior to Date of Motility/GI Physiology Laboratory Test a COVID‐ 19 Test is Required Verify COVID‐19 Test Results: Document COVID‐19 Results Perform Motility/GI Physiology Laboratory Test Using Recommended PPE Thoroughly Clean Motility/GI Physiology Laboratory Suite Between Each Patient Reprocess Catheters Using Manufacturer Recommended Instruction for Use (IFU) 11 Joint ACG/ANMS Webinar Restarting Your Motility Practice • High‐Efficiency Particulate Air (HEPA) Filters: • Device used to prevent airborne infections • Filters up to 99.7% of airborne particles of 0.3 μm in diameter • Time and Speed • Adjusted by the number of exchanges and square foot of the Motility/GI Physiology Laboratory suite • If HEPA is unavailable: • Follow institutional control measures 12 American College of Gastroenterology 4 6/15/2020 Joint ACG/ANMS Webinar Restarting Your Motility Practice • Personal Protection Equipment (PPE) measures will provide safety for both the Motility/GI Physiology Allied Health Professional and Patient in relation to COVID‐19 • Implementing a COVID‐19 Motility/GI Physiology Laboratory strategic workflow enhances safety and effective communication • Utilizing additional air‐filtration system may be an adjunct to standard institutional quality control measures related to COVID‐19 cleaning standards 13 Joint ACG/ANMS Webinar Restarting Your Motility Practice C. Prakash Gyawali, MD Washington University in St. Louis 14 Joint ACG/ANMS Webinar Restarting Your Motility Practice Most esophageal physiologic testing is elective esophageal manometry has alternatives: barium esophagography, endoscopy, FLIP medical reflux management can proceed without ambulatory reflux monitoring emergent anti-reflux surgery can be performed without physiologic testing neuromodulators and complementary approaches used when reflux symptoms persist Emergent reflux monitoring is hardly ever needed wireless pH monitoring can be performed during endoscopy Esophageal manometry confirms achalasia diagnosis prior to LES disruption symptoms can be temporized by adjusting diet and eating habits botulinum toxin injection during diagnostic endoscopy can provide short term relief a timed upright barium study can demonstrate esophageal outflow obstruction in achalasia FLIP during endoscopy can diagnose achalasia; hydraulic FLIP dilation can treat achalasia Lee YY et al. CGH 2020 15 American College of Gastroenterology 5 6/15/2020 Joint ACG/ANMS Webinar Restarting Your Motility Practice Accepted indications Transit symptoms not explained by endoscopy and/or barium studies Suspicion of major motor disorders (especially achalasia) Assessment of esophageal peristaltic performance Assessment of unexplained esophageal symptoms Diagnosis of rumination syndrome and supragastric belching Evaluation of post fundoplication dysphagia Diagnosis of functional esophageal disorders (by exclusion of major motor disorders) Localization of the LES for appropriate placement of pH and pH-impedance catheters Emerging indications Assessment of morphology and integrity of the esophagogastric junction Measurement of hiatus hernia size Assessment of esophageal peristaltic performance prior to bariatric procedures Savarino E, Roman S, Gyawali CP, et al., Nature Reviews Gastroenterol Hepatol 2017 14:665-676 16 Joint ACG/ANMS Webinar Restarting Your Motility Practice Any form of reflux monitoring off PPI high pre-test probability of reflux, confirmation prior to invasive or long-term GERD therapy any situation with unproven GERD and typical reflux symptoms pH-impedance monitoring off PPI (with limited exceptions) persisting reflux symptoms despite PPI in proven GERD (testing performed on PPI) suspicion of reflux-related micro-aspiration, especially pre-lung transplant repetitive belching syndromes suspicion of rumination syndrome persistent symptoms following invasive antireflux procedures Wireless pH monitoring off PPI intolerance of the transnasal catheter infrequent symptoms, where reflux-symptom association is needed high clinical suspicion of GERD but negative 24-hour reflux monitoring very low clinical suspicion of GERD, to rule out GERD Sifrim D, Gyawali CP. Am J Gastroenterol 2020 17 Joint ACG/ANMS Webinar Restarting Your Motility Practice Clinical Qualifiers Alternative approach if procedure is not available HRM in suspected achalasia Significant dysphagia with inability to EGD with endotracheal intubation and with severe symptoms maintain hydration and nutrition. FLIP for diagnosis. Barium esophagography for diagnosis. EGD with endotracheal intubation and Dobhoff tube or gastrostomy tube placement if treatment is delayed. HRM prior to achalasia Plans for urgent management (PD or EGD with endotracheal intubation and management myotomy) FLIP followed by pneumatic dilation. EGD with endotracheal intubation, FLIP and botulinum toxin injection. Barium esophagography for diagnosis (if no prior confirmation of diagnosis) and myotomy referral. HRM prior to hernia Large hiatus hernia, risk for aspiration or Barium esophagography for diagnosis. surgery volvulus. Inability to maintain hydration *Evidence of ischemia: proceed to and nutrition. emergent surgery Lee YY et al. CGH 2020; ANMS Task Force document 2020, motilitysociety.org 18 American College of Gastroenterology 6 6/15/2020 Joint ACG/ANMS Webinar Restarting Your Motility Practice Clinical Qualifiers Alternative approach if procedure is not available HRM Dysphagia with weight loss Empiric management with PPI, (Transition to an urgent
Recommended publications
  • Regions Hospital Delineation of Privileges Surgery

    Regions Hospital Delineation of Privileges Surgery

    Regions Hospital Delineation of Privileges Surgery Applicant’s Name: ____________________________________________________________________________ Last First M. Instructions: Place a check-mark where indicated for each core group you are requesting. Review education and basic formal training requirements to make sure you meet them. Review documentation and experience requirements and be prepared to prove them. Note all renewing applicants are required to provide evidence of their current ability to perform the privileges being requested\ When documentation of cases or procedures is required, attach said case/procedure logs to this privileges-request form. Provide complete and accurate names and addresses where requested -- it will greatly assist how quickly our credentialing-specialist can process your requests. Overview: (Applicant should check all core privileges you are requesting) Core I – General Staff Privileges in Surgery Core II – General Staff Privileges in Trauma (Adult and Pediatric) Core III – Pediatric Trauma Rounding Privileges Core IV – General Staff Privileges in Burn Core V – General Staff Privileges in Colon and Rectal Surgery Core VI – General Staff Privileges in Vascular Surgery Core VII – General Staff Privileges in Surgical Critical Care Special Privileges Also included are: Core Procedure Lists Signature Page Page 1 of 24 06.2015 CORE I -- General Staff Privileges in Surgery (Appointments are based on the needs of the Department of Surgery as determined by the Division Head of Surgery and Hospital Board) Privileges Privileges include the performance of surgical procedures (including related admission, consultation, work-up, pre- and post-operative care) to correct or treat various conditions, illnesses and injuries of the: alimentary tract, including colon and rectum, abdomen and its contents, breasts, skin, and soft tissue, head and neck, endocrine system and vascular system, excluding the intercranial vessels, the heart and those vessels intrinsic and immediately adjacent thereto.
  • The Practice of Gastrointestinal Motility Laboratory During COVID-19 Pandemic

    The Practice of Gastrointestinal Motility Laboratory During COVID-19 Pandemic

    J Neurogastroenterol Motil, Vol. 26 No. 3 July, 2020 pISSN: 2093-0879 eISSN: 2093-0887 https://doi.org/10.5056/jnm20107 JNM Journal of Neurogastroenterology and Motility Review The Practice of Gastrointestinal Motility Laboratory During COVID-19 Pandemic: Position Statements of the Asian Neurogastroenterology and Motility Association (ANMA-GML-COVID-19 Position Statements) Kewin T H Siah,1,2* M Masudur Rahman,3 Andrew M L Ong,4,5 Alex Y S Soh,1,2 Yeong Yeh Lee,6,7 Yinglian Xiao,8 Sanjeev Sachdeva,9 Kee Wook Jung,10 Yen-Po Wang,11 Tadayuki Oshima,12 Tanisa Patcharatrakul,13,14 Ping-Huei Tseng,15 Omesh Goyal,16 Junxiong Pang,17 Christopher K C Lai,18 Jung Ho Park,19 Sanjiv Mahadeva,20 Yu Kyung Cho,21 Justin C Y Wu,22 Uday C Ghoshal,23 and Hiroto Miwa12 1Department of Medicine, Yong Loo Lin School of Medicine, The National University of Singapore, Singapore; 2Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore; 3Department of Gastroenterology, Sheikh Russel National Gastroliver Institute and Hospital, Dhaka, Bangladesh; 4Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore; 5Duke-NUS Medical School, Singapore; 6School of Medical Sciences, Universiti Sains Malaysia, Malaysia; 7St George and Sutherland Clinical School, University of New South Wales, Kogarah, NSW, Australia; 8Department of Gastroenterology and Hepatology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; 9Department of Gastroenterology, GB Pant Hospital, New Delhi, India;
  • Anal Cancer Anal Cancer, Also Known As Anal Carcinoma, Is Cancer of the Anus

    Anal Cancer Anal Cancer, Also Known As Anal Carcinoma, Is Cancer of the Anus

    Anal Cancer Anal cancer, also known as anal carcinoma, is cancer of the anus. To help diagnose this condition, your doctor will perform a digital rectal exam and anoscopy. An MRI, CT, PET/CT, or an endoanal ultrasound may also be ordered by your doctor. Depending on the size, location, and extent of the cancer, treatments may include surgery, radiation therapy and chemotherapy. What is anal cancer? Anal cancer is a cancer that begins in the anus, the opening at the end of the gastrointestinal tract through which stool, or solid waste, leaves the body. The anus begins at the bottom of the rectum, which is the last part of the large intestine (also called the colon). Anal cancer usually affects adults over age 60 and women more often than men. More than 8,000 people in the U.S. are diagnosed with anal cancer each year. Anal cancer symptoms may include changes in bowel habits and changes in and around the anal area, including: bleeding and itching pain or pressure unusual discharge a lump or mass fecal incontinence fistulae. Some patients with anal cancers do not experience any symptoms. Some non-cancerous conditions, such as hemorrhoids and fissures, may cause similar symptoms. How is anal cancer diagnosed and evaluated? To diagnose the cause of symptoms, your doctor may perform: Digital rectal examination (DRE): Digital Rectal Exam (DRE): This test examines the lower rectum and the prostate gland in males to check for abnormalities in size, shape or texture. The term "digital" refers to the clinician's use of a gloved lubricated finger to conduct the exam.
  • Is Digital Rectal Exam Reliable in Grading Anal Sphincter Defects?

    Is Digital Rectal Exam Reliable in Grading Anal Sphincter Defects?

    DOI: 10.1590/S0004-28032016000400006 ARQGA/1864 IS DIGITAL RECTAL EXAM RELIABLE IN GRADING ANAL SPHINCTER DEFECTS? Marcelo de Melo Andrade COURA, Silvana Marques SILVA, Romulo Medeiros de ALMEIDA, Miles Castedo FORREST and João Batista SOUSA Received 7/7/2015 Accepted 14/8/2015 ABSTRACT - Background - Anal sphincter tone is routinely assessed by digital rectal examination in patients with fecal incontinence, although its accuracy in detecting sphincter defects or separating competent from incompetent muscles has not been established. Objective - In this setting, we aimed to evaluate the accuracy of digital rectal examination in grading anal defects in order to sepa- rate small from extensive cases as depicted on 3D endoanal ultrasound, using a scoring sphincter defect and correlate anal tone to anal pressures. Methods - Women with fecal incontinence were divided into two groups: small or extensive defects according to the ultrasound scoring system. Sensitivity, specificity, positive and negative predictive values of digital rectal examination in grading global and external sphincter defects were calculated. Anal tone at digital rectal examination was compared to resting and incremen- tal pressures. Results - A cohort of 76 consecutive incontinent women were enrolled. The median Wexner score was 9. Sixty-eight showed sphincter defects on 3D endoanal ultrasound. Anal tone at digital rectal examination was considered abnormal in 62 cases. Abnormal digital rectal examination showed a sensitivity of 90%, specificity of 27.78% in distinguishing small from extensive defects of both sphincters. Five out of eight women with no sphincter defects had only abnormal squeeze tone at digital rectal examination. Abnormal squeeze tone at digital rectal examination had a sensitivity of 65.31% in distinguishing small from extensive external anal sphincter defects.
  • Biodegradable Esophageal Stents for the Treatment of Refractory Benign Esophageal Strictures

    Biodegradable Esophageal Stents for the Treatment of Refractory Benign Esophageal Strictures

    INVITED REVIEW Annals of Gastroenterology (2020) 33, 1-8 Biodegradable esophageal stents for the treatment of refractory benign esophageal strictures Paraskevas Gkolfakisa, Peter D. Siersemab, Georgios Tziatziosc, Konstantinos Triantafyllouc, Ioannis S. Papanikolaouc Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium; Radboud University Medical Center, Nijmegen, The Netherlands; “Attikon” University General Hospital, Medical School, National and Kapodistrian University of Athens, Greece Abstract This review attempts to present the available evidence regarding the use of biodegradable stents in refractory benign esophageal strictures, especially highlighting their impact on clinical success and complications. A comprehensive literature search was conducted in PubMed, using the terms “biodegradable” and “benign”; evidence from cohort and comparative studies, as well as data from one pooled analysis and one meta-analysis are presented. In summary, the results from these studies indicate that the effectiveness of biodegradable stents ranges from more than one third to a quarter of cases, fairly similar to other types of stents used for the same indication. However, their implementation may reduce the need for re-intervention during follow up. Biodegradable stents also seem to reduce the need for additional types of endoscopic therapeutic modalities, mostly balloon or bougie dilations. Results from pooled data are consistent, showing moderate efficacy along with a higher complication rate. Nonetheless, the validity of these results is questionable, given the heterogeneity of the studies included. Finally, adverse events may occur at a higher rate but are most often minor. The lack of high-quality studies with sufficient patient numbers mandates further studies, preferably randomized, to elucidate the exact role of biodegradable stents in the treatment of refractory benign esophageal strictures.
  • Endorectal, Endoanal and Perineal Ultrasound

    Endorectal, Endoanal and Perineal Ultrasound

    Review Nuernberg Dieter et al. EFSUMB Recommendations for Gastrointestinal … Ultrasound Int Open 2018; 00: 00–00 EFSUMB Recommendations for Gastrointestinal Ultrasound Part 3: Endorectal, Endoanal and Perineal Ultrasound Authors Dieter Nuernberg1,*, Adrian Saftoiu2,*, Ana Paula Barreiros3, Eike Burmester4, Elena Tatiana Ivan2, Dirk-André Clevert5, Christoph F. Dietrich6, Odd Helge Gilja7, Torben Lorentzen8, Giovanni Maconi9, Ismail Mihmanli10, Christian Pallson Nolsoe11, Frank Pfeffer12, Søren Rafael Rafaelsen13, Zeno Sparchez14, Peter Vilmann15, Jo Erling Riise Waage12 Affiliations Key words 1 Medical School Brandenburg Theodor Fontane, endorectal ultrasound, endoanal ultrasound, perineal ultrasound Gastroenterology, Neuruppin, Germany received 07.04.2018 2 Research Center in Gastroenterology and Hepatology, revised 23.11.2018 University of Medicine and Pharmacy Craiova, Craiova, accepted 01.12.2018 Romania 3 Deutsche Stiftung Organtransplantation, Head of Bibliography Organisation Center Middle, Frankfurt, Germany DOI https://doi.org/10.1055/a-0825-6708 4 Department of Internal Medicine/Gastroenterology, Published online: 2019 Sana-Kliniken Lübeck, Lübeck, Germany Ultrasound Int Open 2019; 5: E34–E51 5 Department of Clinical Radiology, Interdisciplinary © Georg Thieme Verlag KG Stuttgart · New York Ultrasound-Center, University of Munich-Grosshadern ISSN 2199-7152 Campus, Munich, Germany 6 Caritas-Krankenhaus, Medizinische Klinik 2, Bad Correspondence Mergentheim, Germany Prof. Adrian Saftoiu 7 National Centre for Ultrasound in Gastroenterology,
  • Advances in Flexible Endoscopy

    Advances in Flexible Endoscopy

    Advances in Flexible Endoscopy Anant Radhakrishnan, DVM KEYWORDS Flexible endoscopy Minimally invasive procedures Gastroduodenoscopy Minimally invasive surgery KEY POINTS Although some therapeutic uses exist, flexible endoscopy is primarily used as a diagnostic tool. Several novel flexible endoscopic procedures have been studied recently and show prom- ise in veterinary medicine. These procedures provide the clinician with increased diagnostic capability. As the demand for minimally invasive procedures continues to increase, flexible endos- copy is being more readily investigated for therapeutic uses. The utility of flexible endoscopy in small animal practice should increase in the future with development of the advanced procedures summarized herein. INTRODUCTION The demand for minimally invasive therapeutic measures continues to increase in hu- man and veterinary medicine. Pet owners are increasingly aware of technology and diagnostic options and often desire the same care for their pet that they may receive if hospitalized. Certain diseases, such as neoplasia, hepatobiliary disease, pancreatic disease, and gastric dilatation–volvulus, can have significant morbidity associated with them such that aggressive, invasive measures may be deemed unacceptable. Even less severe chronic illnesses such as inflammatory bowel disease can be asso- ciated with frustration for the pet owner such that more immediate and detailed infor- mation regarding their pet’s disease may prove to be beneficial. Minimally invasive procedures that can increase diagnostic and therapeutic capability with reduced pa- tient morbidity will be in demand and are therefore an area of active investigation. The author has nothing to disclose. Department of Internal Medicine, Bluegrass Veterinary Specialists 1 Animal Emergency, 1591 Winchester Road, Suite 106, Lexington, KY 40505, USA E-mail address: [email protected] Vet Clin Small Anim 46 (2016) 85–112 http://dx.doi.org/10.1016/j.cvsm.2015.08.003 vetsmall.theclinics.com 0195-5616/16/$ – see front matter Ó 2016 Elsevier Inc.
  • Obstetric Anal Sphincter Injury Detection Using Impedance Spectroscopy with the ONIRY Probe

    Obstetric Anal Sphincter Injury Detection Using Impedance Spectroscopy with the ONIRY Probe

    applied sciences Article Obstetric Anal Sphincter Injury Detection Using Impedance Spectroscopy with the ONIRY Probe Marcel Mły ´nczak 1 , Maciej Rosoł 1 , Antonino Spinelli 2,3 , Adam Dziki 4 , Edyta Wla´zlak 5 , Grzegorz Surkont 5 , Magda Krzycka 5 , Paulina Paj ˛ak 5 , Łukasz Dziki 4 , Michał Mik 4 and Katarzyna Borycka-Kiciak 6,* 1 Faculty of Mechatronics, Institute of Metrology and Biomedical Engineering, Warsaw University of Technology, 02-525 Warsaw, Poland; [email protected] (M.M.); [email protected] (M.R.) 2 Humanitas Clinical and Research Center—IRCCS, 20089 Milan, Italy; [email protected] 3 Department of Biomedical Sciences, Humanitas University, 20090 Milan, Italy 4 Department of General and Colorectal Surgery, Medical University of Lodz, 90-647 Lodz, Poland; [email protected] (A.D.); [email protected] (Ł.D.); [email protected] (M.M.) 5 First Department of Gynecology and Obstetrics, Clinic for Gynecological Surgery and Oncology, Medical University of Lodz, 94-029 Lodz, Poland; [email protected] (E.W.); [email protected] (G.S.); [email protected] (M.K.); [email protected] (P.P.) 6 Centre of Postgraduate Medical Education, Department of Colorectal, General and Oncological Surgery, 01-813 Warsaw, Poland * Correspondence: [email protected] Featured Application: Impedance spectroscopy performed using ONIRY can be used to screen for possible obstetric anal sphincter injury just after natural delivery, allowing the start of necessary treatment or rehabilitation. Citation: Mły´nczak,M.; Rosoł, M.; Abstract: Anal sphincter injuries occurring during natural deliveries are often a reason for severe Spinelli, A.; Dziki, A.; Wla´zlak,E.; Surkont, G.; Krzycka, M.; Paj ˛ak,P.; complications, including fecal incontinence.
  • 1 Dr. Melody Joy V. Mique Biochemistry of Digestion 2

    1 Dr. Melody Joy V. Mique Biochemistry of Digestion 2

    DR. MELODY JOY V. MIQUE BIOCHEMISTRY OF DIGESTION 2 UNIT IV BIOCHEMISTRY OF DIGESTION 2 OBJECTIVE: 1. Explain the chemical reactions involved in the process of digestion. 2. Analyze certain basic biochemical processes to explain commonly occurring health- related problems in digestion 3. Discuss the digestion of complex biomolecules in the body; TOPICS Unit 4: BIOCHEMISTRY OF DIGESTION 3. Chemical changes in the 1. Definition and factors affecting Digestion large intestines and feces 2. Phases of Digestion a. Fermentation a. Salivary Digestion b. Putrefaction b. Gastric Digestion c. Deamination c. Intestinal Digestion d. Decarboxylation d. Pancreatic Juice e. Detoxification e. Intestinal Juice 4. Feces and its Chemical Composition f. Bile CHEMICAL CHANGES IN THE LARGE INTESTINE AND FECES, CHEMICAL COMPOSITION OF FECES The large intestine, also known as colon or the the large bowel, is the last part of the gastrointestinal tract and of the digestive system in vertebrates. The digestive tract includes the mouth, esophagus, stomach, small intestine, large intestine and the rectum. There are 4 major functions of the large intestine: 1. recovery of water and electrolytes (Na, Cl etc) 2. formation and temporary storage of feces 3. maintaining a resident population of over 500 species of bacteria 3. fermentation of some of the indigestible food matter by bacteria. By the time partially digested foodstuffs reach the end of the small intestine (ileum), about 80% of the water content will be absorbed by the large intestine. The colon absorbs most of the remaining water. As the remnant food material moves through the colon, it is mixed with bacteria and mucus, and formed into feces for temporary storage before being eliminated by defecation In humans, the large intestine begins in the right iliac region of the pelvis, just at or below the waist, where it is joined to the end of the small intestine at the cecum, via the ileocecal valve.
  • Endorectal, Endoanal and Perineal Ultrasound

    Endorectal, Endoanal and Perineal Ultrasound

    University of Southern Denmark EFSUMB Recommendations for Gastrointestinal Ultrasound Part 3 Endorectal, Endoanal and Perineal Ultrasound Nuernberg, Dieter; Saftoiu, Adrian; Barreiros, Ana Paula; Burmester, Eike; Ivan, Elena Tatiana; Clevert, Dirk-André; Dietrich, Christoph F; Gilja, Odd Helge; Lorentzen, Torben; Maconi, Giovanni; Mihmanli, Ismail; Nolsoe, Christian Pallson; Pfeffer, Frank; Rafaelsen, Søren Rafael; Sparchez, Zeno; Vilmann, Peter; Waage, Jo Erling Riise Published in: Ultrasound International Open DOI: 10.1055/a-0825-6708 Publication date: 2019 Document version: Final published version Document license: CC BY-NC-ND Citation for pulished version (APA): Nuernberg, D., Saftoiu, A., Barreiros, A. P., Burmester, E., Ivan, E. T., Clevert, D-A., Dietrich, C. F., Gilja, O. H., Lorentzen, T., Maconi, G., Mihmanli, I., Nolsoe, C. P., Pfeffer, F., Rafaelsen, S. R., Sparchez, Z., Vilmann, P., & Waage, J. E. R. (2019). EFSUMB Recommendations for Gastrointestinal Ultrasound Part 3: Endorectal, Endoanal and Perineal Ultrasound. Ultrasound International Open, 5(1), E34-E51. https://doi.org/10.1055/a- 0825-6708 Go to publication entry in University of Southern Denmark's Research Portal Terms of use This work is brought to you by the University of Southern Denmark. Unless otherwise specified it has been shared according to the terms for self-archiving. If no other license is stated, these terms apply: • You may download this work for personal use only. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying this open access version If you believe that this document breaches copyright please contact us providing details and we will investigate your claim.
  • Sacral Neuromodulation System Neurostimulator Implant Manual

    Sacral Neuromodulation System Neurostimulator Implant Manual

    Sacral Neuromodulation System Neurostimulator Implant Manual Model 1101 Neurostimulator Rx only Axonics®, Axonics Modulation®, Axonics Modulation Technologies® and Axonics Sacral Neuromodulation System® are trademarks of Axonics Modulation Technologies, Inc., registered or pending registration in the U.S. and other countries. Axonics Modulation Technologies, Inc. 26 Technology Drive Irvine, CA 92618 (USA) www.axonicsmodulation.com Tel. +1-877-929-6642 Fax +1-949 396-6321 LABEL SYMBOLS This section explains the symbols found on the product and packaging. Symbol Description Symbol Description Refer to instructions for use (Consult accompanying documents) Axonics Neurostimulator Temperature limitation Axonics Torque Wrench Humidity limitation Neurostimulator default waveform with 14 Hz frequency, 0 mA Pressure limitation amplitude and 210 ms pulse width Do not reuse Neurostimulator default electrode configuration: Electrode 0: Negative (-) Electrode 1: Off (0) Sterilized using Ethylene oxide Electrode 2: Off (0) Electrode 3: Positive (+) Use by Case: Off (0) Authorized representative in the European community Open here Do not use if package is damaged Product Serial Number Do not resterilize For USA audiences only Manufacturer !USA Rx ONLY Caution: U.S. Federal law restricts this device for sale by or on the order of a physician Product Model Number Warning / Caution Manufacturing Date Product Literature Non ionizing electromagnetic radiation Magnetic Resonance (MR) Conditional FCC ID US Federal Communications Commission device identification IC Industry Canada certification number Conformité Européenne (European Conformity). This symbol means This device complies with all applicable Australian Communica- that the device fully complies with AIMD Directive 90/385/EEC R-NZtions and Media Authority (ACMA) regulatory arrangements and (Notified Body reviewed) and RED 2014/53/EU (self-certified) electrical equipment safety requirements 3 TABLE OF CONTENTS LABEL SYMBOLS .
  • Evaluation of Diagnostic Accuracy of 3-D Endoanal Ultrasound In

    Evaluation of Diagnostic Accuracy of 3-D Endoanal Ultrasound In

    j coloproctol (rio j). 2 0 1 8;3 8(1):9–12 Journal of Coloproctology www.jcol.org.br Original Article Evaluation of diagnostic accuracy of 3-D endoanal ultrasound in perianal fistula in comparison with intraoperative findings a a,∗ b c Ehsan Rahmanian , Mojgan Frootan , Fakhri Anaraki , Elahe Alimadadi , d Mahsa Ramezanpoor a Shahid Beheshti of Medical Sciences, Tehran, Iran b Ayatollah Taleghani Hospital, Surgery Department, Tehran, Iran c Shahid Beheshti of Medical Sciences, Research Institute for Gastroenterology and Liver Diseases, Tehran, Iran d Shahid Sadoughi University of Medical Sciences, Research Center – Treatment of Diabetes, Tehran, Iran a r t a b i c s t l e i n f o r a c t Article history: Objective: Perianal fistula is a common and debilitating disease. The definite treatment is Received 24 May 2017 surgery, identifying of primary and secondary tract, internal opening of fistula has important Accepted 26 August 2017 role in planning of surgical techniques. This study’s goal was to determine the diagnostic Available online 26 November 2017 accuracy of 3-D ultrasound in perianal fistula in comparison with intraoperative findings. Materials and methods: This study is a cross-sectional study. Adult patients (18–85 years old) Keywords: with anal fistula have been selected. 3-D EUS was done for all patients by gastroenterologist. Then surgery was done. Check lists filled by endoscopist and surgeon was studied and data Anal fistula Three dimensional endoscopic analysis was done. ultrasounds Results: The study examined 76 patients, in according to results for kappa coefficient there Surgery was a perfect agreement between 3-D ultrasound results and surgery in internal opening that was 96% (p < 0.001) and concordance was 0.974.